Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Dynavax Technologies Stock Sees Relative Strength Rating Rise To 85
04:15pm, Friday, 25'th Feb 2022 Investor''s Business Daily
Dynavax Technologies sees its Relative Strength Rating move into the 80-plus level.
Dynavax to Present at the Cowen 42nd Annual Health Care Conference
09:05pm, Wednesday, 23'rd Feb 2022 Investors Dynavax
EMERYVILLE, Calif. , Feb. 23, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer , Chief Executive Officer and Kelly MacDonald Chief Financial Officer, will
Dynavax to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022
09:05pm, Wednesday, 16'th Feb 2022 PR Newswire
EMERYVILLE, Calif., Feb. 16, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company focused on developing and commercializing innovative vaccines, will report fourth quarter and full year 2021 financial results on Monday,…
Why Novavax, Dynavax, and Ocugen Are All Rising Today
12:40pm, Tuesday, 15'th Feb 2022
A broad stock market rebound and an encouraging survey appear to be boosting these vaccine stocks.
Will Dynavax's (DVAX) Growth Momentum Continue in 2022?
12:20pm, Tuesday, 15'th Feb 2022
Year-over-year revenue growth for HEPLISAV-B and CpG 1018 adjuvant is expected to drive Dynavax???s (DVAX) profitability in 2022.
4 Top Biotech Stocks to Gain Amid Industry Challenges
09:59am, Tuesday, 01'st Feb 2022
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and pipeline progress position VRTX, REGN, DVA
Amgen''s (AMGN) KRAS Inhibitor Gets Nod in Japan for Lung Cancer | Investing.com
07:40pm, Friday, 21'st Jan 2022 Investing.com
Stocks Analysis by Zacks Investment Research covering: Amgen Inc, Dynavax Technologies Corporation, Mirati Ther, AnaptysBio Inc. Read Zacks Investment Research''s latest article on Investing.com
New Strong Buy Stocks for January 21st
06:59am, Friday, 21'st Jan 2022
ARCB, BCC, DVAX, FCX, and JBHT have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2022.
Dynavax: Vaccine Stalwart Coming Of Age
02:16am, Tuesday, 18'th Jan 2022
Dynavax: Vaccine Stalwart Coming Of Age
Dynavax: A Coronavirus Growth Story
08:00am, Monday, 17'th Jan 2022
Dynavax will continue to grow for as long as the pandemic lasts.
Dynavax reinstated Buy at Goldman Sachs on potential of adjuvant, HBV prospects
02:04pm, Thursday, 06'th Jan 2022 Seeking Alpha
Dynavax Technologies (DVAX) is trading ~4.8% higher in the pre-market after Goldman Sachs reinstated its coverage on Wednesday with a Buy recommendation citing the potential of
Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference
09:05pm, Wednesday, 05'th Jan 2022 Business Insider Markets
EMERYVILLE, Calif., Jan. 5, 2022 /PRNewswire/ -- Dynavax Technologies Corporation
Is Dynavax Technologies (DVAX) Stock Outpacing Its Medical Peers This Year?
10:43am, Friday, 31'st Dec 2021
Here is how Dynavax Technologies (DVAX) and Omnicell (OMCL) have performed compared to their sector so far this year.
Why Dynavax Stock Zoomed Higher Today
05:55pm, Wednesday, 29'th Dec 2021
One analyst gets notably more bullish on the biotech's shares.
Dynavax Technologies (NASDAQ:DVAX) Stock Price Down 3.9%
11:04am, Friday, 24'th Dec 2021 Transcript Daily
Shares of Dynavax Technologies Co. (NASDAQ:DVAX) were down 3.9% during mid-day trading on Wednesday . The company traded as low as $13.66 and last traded at $13.68. Approximately 5,540 shares traded hands during trading, a decline of 100% from the average daily volume of 3,946,220 shares. The stock had previously closed at $14.23. Several research […]
